Jupiter Neurosciences Launches Nugevia™ Longevity Supplement Line to Drive Revenue While Developing CNS Treatments
Jupiter Neurosciences Inc. has launched its Nugevia™ direct-to-consumer longevity supplement line, leveraging its patented JOTROL™ resveratrol formulation to generate immediate revenue while continuing pharmaceutical development for central nervous system disorders.
